PMID- 28366194 OWN - NLM STAT- MEDLINE DCOM- 20170731 LR - 20181202 IS - 1477-2566 (Electronic) IS - 1465-3249 (Linking) VI - 19 IP - 5 DP - 2017 May TI - Effects of a defined xeno-free medium on the growth and neurotrophic and angiogenic properties of human adult stem cells. PG - 629-639 LID - S1465-3249(17)30424-3 [pii] LID - 10.1016/j.jcyt.2017.02.360 [doi] AB - BACKGROUND: The growth properties and neurotrophic and angiogenic effects of human mesenchymal stromal cells (MSCs) cultured in a defined xeno-free, serum-free medium (MesenCult-XF) were investigated. METHODS: Human MSCs from adipose tissue (ASCs) and bone marrow (BMSCs) were cultured in Minimum Essential Medium-alpha (alpha-MEM) containing fetal calf serum or in MesenCult-XF. Proliferation was measured over 10 passages and the colony-forming unit (CFU) assay and expression of cluster of differentiation (CD) surface markers were determined. Neurite outgrowth and angiogenic activity of the MSCs were determined. RESULTS: At early passage, both ASCs and BMSCs showed better proliferation in MesenCult-XF compared with standard alpha-MEM-containing serum. However, CFUs were significantly lower in MesenCult-XF. ASCs cultured in MesenCult-XF continued to expand at faster rates than cells grown in serum. BMSCs showed morphological changes at late passage in MesenCult-XF and stained positive for senescence beta-galactosidase activity. Expression levels of CD73 and CD90 were similar in both cell types under the various culture conditions but CD105 was significantly reduced at passage 10 in MesenCult-XF. In vitro stimulation of the cells enhanced the expression of brain-derived neurotrophic factor (BDNF), vascular endothelial growth factor (VEGF-A) and angiopoietin-1. Stimulated ASCs grown in MesenCult-XF evoked the longest neurite outgrowth in a neuron co-culture model. Stimulated BMSCs grown in MesenCult-XF produced the most extensive network of capillary-like tube structures in an in vitro angiogenesis assay. CONCLUSIONS: ASCs and BMSCs exhibit high levels of neurotrophic and angiogenic activity when grown in the defined serum-free medium indicating their suitability for treatment of various neurological conditions. However, long-term expansion in MesenCult-XF might be restricted to ASCs. CI - Copyright (c) 2017 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved. FAU - Brohlin, Maria AU - Brohlin M AD - Division of Clinical Immunology and Transfusion Medicine, Tissue Establishment, Cell Therapy Unit, Department of Laboratory Medicine, Umea University Hospital, Umea, Sweden. Electronic address: maria.brohlin@vll.se. FAU - Kelk, Peyman AU - Kelk P AD - Department of Integrative Medical Biology, Anatomy, Umea University, Umea, Sweden. FAU - Wiberg, Mikael AU - Wiberg M AD - Department of Integrative Medical Biology, Anatomy, Umea University, Umea, Sweden; Department of Surgical and Perioperative Sciences, Hand and Plastic Surgery, Umea University, Umea, Sweden. FAU - Kingham, Paul J AU - Kingham PJ AD - Department of Integrative Medical Biology, Anatomy, Umea University, Umea, Sweden. LA - eng PT - Journal Article PL - England TA - Cytotherapy JT - Cytotherapy JID - 100895309 RN - 0 (Culture Media) RN - 0 (Nerve Growth Factors) RN - 0 (Vascular Endothelial Growth Factor A) SB - IM MH - Adipogenesis/drug effects MH - Adipose Tissue/cytology MH - Adult MH - Adult Stem Cells/*cytology/drug effects MH - Cell Proliferation/drug effects MH - Cells, Cultured MH - Culture Media MH - Flow Cytometry MH - Humans MH - Mesenchymal Stem Cells/cytology MH - Neovascularization, Physiologic/*drug effects MH - Nerve Growth Factors/*pharmacology MH - Neurites/drug effects/metabolism MH - Vascular Endothelial Growth Factor A/metabolism OTO - NOTNLM OT - adipose OT - bone marrow OT - clinical cell culture OT - mesenchymal stromal cells OT - neurotrophic factors EDAT- 2017/04/04 06:00 MHDA- 2017/08/02 06:00 CRDT- 2017/04/04 06:00 PHST- 2016/09/20 00:00 [received] PHST- 2017/02/22 00:00 [revised] PHST- 2017/02/24 00:00 [accepted] PHST- 2017/04/04 06:00 [entrez] PHST- 2017/04/04 06:00 [pubmed] PHST- 2017/08/02 06:00 [medline] AID - S1465-3249(17)30424-3 [pii] AID - 10.1016/j.jcyt.2017.02.360 [doi] PST - ppublish SO - Cytotherapy. 2017 May;19(5):629-639. doi: 10.1016/j.jcyt.2017.02.360.